ConductScience.org, home

Trial · NCT07759687

Lion's Mane Dosing on Attention and Mood

NCT07759687, Not applicable, Not yet recruiting, Northumbria University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Lion's Mane Dosing on Attention and Mood. Trials, record NCT07759687. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07759687

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Lion's Mane Dosing on Attention and Mood
NCT number
NCT07759687
Status
Not yet recruiting
Phases
Not applicable
Enrollment
24 participants, estimated
Lead sponsor
Northumbria University
Conditions
Attention
Interventions
Lion's Mane fruiting bodies extract, Placebo
First posted
2026-08-12
Last updated
2026-08-12

Source ClinicalTrials.gov

Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySpeed of AttentionBaseline, 60-, 120-, 180- and 300 minutes post dose
Speed of Attention cognitive domain, calculated from reaction time (msec) performance on the following tasks: Choice Reaction Time, 4 Choice Reaction Time, Digit Vigilance, Arrow Flankers, Stroop, Rapid Visual Information Processing.
SecondaryAccuracy of AttentionBaseline, 60-, 120-, 180- and 300 minutes post dose
Accuracy of Attention cognitive domain, calculated from accuracy of performance (%) on the following tasks: Choice Reaction Time, 4 Choice Reaction Time, Digit Vigilance, Arrow Flankers, Stroop, Rapid Visual Information Processing.
SecondaryChoice Reaction TimeBaseline, 60-, 120-, 180- and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Measuring attention and vigilance. Choice Reaction Time (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance.
Secondary4 Choice Reaction TimeBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. 4 Choice Reaction Time (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance.
SecondaryDigit VigilanceBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. Digit Vigilance (% accuracy, reaction time (msec), false alarms). With higher accuracy, lower false alarms and quicker reaction time indicating better performance.
SecondaryArrow FlankersBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention and vigilance. Arrow Flankers (% accuracy, reaction time (msec). With higher accuracy and quicker reaction time indicating better performance.
SecondaryStroopBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses attention, vigilance and executive function. Stroop Task (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance.
SecondaryNumeric Working MemoryBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task measures working memory. Numeric Working Memory (% accuracy, reaction time (msec)). With higher accuracy and quicker reaction time indicating better performance.
SecondarySerial Subtraction of three'sBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task measures working memory and cognitive demand. Serial subtraction of three's (number of correct responses, number of error responses). With more correct responses and less error responses indicating better performance.
SecondarySerial Subtraction on Seven'sBaseline, 60-, 120, 180-, and 300 minutes post dose
Administered by the cognitive battery Computerised Mental Performance Assessment System (COMPASS). Task assesses working memory and cognitive demand. Serial subtraction of seven's (number correct responses, number error responses). With more correct responses and less errors indicating better performance.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Choice Reaction TimePrimary outcomeConductCognition
Eriksen Flanker TaskPrimary outcomeConductCognition
Rapid Visual Information ProcessingPrimary outcomeConductCognition
Arithmetic Fluency TaskSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07759687

GET https://conductscience.org/api/trials/v1/NCT07759687/registered